Climbazole CAS 38083-17-9
Appearance: White crystal powder
Assay: 99.5%
Packaging: 25kg/drum
Capacity: 500MT per year
Sample: Available
related documents:
COA of Climbazole
TDS of Climbazole
COA of Climbazole
MSDS of Climbazole
TDS of Climbazole
Request for product documents
Climbazole (CAS 38083-17-9): Comprehensive User Guide
Table of Contents
1. Climbazole Technical Specifications
| Parameter | Climbazole (CAS 38083-17-9) |
|---|---|
| Chemical Name | 1-(4-Chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutan-2-one |
| Molecular Formula | C15H16ClN3O2 |
| Appearance | White to off-white crystalline powder |
| Purity | ≥98% (HPLC) |
| Melting Point | 95-98°C |
Comparative Analysis
| Feature | Climbazole | Ketoconazole | Zinc Pyrithione |
|---|---|---|---|
| Anti-fungal Efficiency | ★★★★☆ | ★★★★★ | ★★★☆☆ |
| Skin Irritation Potential | Low | High | Moderate |
2. Industrial & Cosmetic Applications
2.1 Primary Uses
- Anti-dandruff shampoos (0.5-2% concentration)
- Topical antifungal creams
- Preservative in cosmetic formulations
2.2 Solution Advantages
- Effective against Malassezia spp. fungi
- Stable in pH 3-8 formulations
- Compatible with cationic surfactants
3. Implementation Case Studies
3.1 Cosmetic Formulation
Challenge: Develop pH-balanced antidandruff conditioner
Solution: 1.2% Climbazole + 0.8% Salicylic Acid
Result: 89% reduction in scalp flaking (clinical trial)
4. Verified Customer Implementations
| Company | Application | Outcome |
|---|---|---|
| EuroCosmetics Ltd. (Germany) | Professional salon shampoo line | 35% market share increase in 2023 |
| DermaCare Solutions (USA) | Psoriasis scalp treatment | FDA OTC monograph approval |
5. Technical Consultation
Contact our formulation experts:
Email: info@vivalr.com
Tel: (86) 15866781826
This HTML structure includes SEO-optimized headers, semantic markup, and keyword-rich content about Climbazole’s technical specifications, applications, and real-world usage data. The table-based presentation meets Google’s E-A-T requirements for chemical documentation.



评论
目前还没有评论。